Novadoz recalls Glycopyrrolate Oral Solution 1 mg/5 mL because it failed impurity and breakdown tests
Failed Impurities/Degradation Specifications.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Company
- Novadoz Pharmaceuticals LLC
- Hazard
- Failed Impurities/Degradation Specifications
- Units
- N/A
- Where sold
- US Nationwide.
- FDA classification
- Class III · Ongoing
- Classified by FDA
- January 28, 2026
- Recall started
- December 15, 2025
- FDA enforcement report
- February 4, 2026
- Identifiers
- Codes: Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
- FDA recall number: D-0300-2026
Details are taken from the official notice. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Reason for recall
- Failed Impurities/Degradation Specifications
- Classification
- Class III (Ongoing)
- Distribution
- US Nationwide.
- Quantity
- N/A
Related recalls
Precision Dose recalls Glycopyrrolate Oral Solution 1 mg/5 mL syringes because it failed impurity limits
The glycopyrrolate oral solution in unit-dose oral syringes failed its impurities and degradation specifications, and the notice does not say what this could do to a person.